Company intelligence / Profile preview
InteguRx Therapeutics
Whitehouse Station, New Jersey, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
InteguRx Therapeutics is a development-stage U.S. biotech company specializing in proprietary fatty acid-based transdermal drug delivery systems for underserved indications in women’s health and cardiology, with its two current lead programs focused on a transdermal ondansetron patch for pregnancy-induced nausea and vomiting and a transdermal apixaban patch for atrial fibrillation, both in IND-enabling/preclinical development.
- Therapeutic areas
- CardiovascularWomen's Health
- Modalities
- Transdermal drug delivery system
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on InteguRx Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InteguRx Therapeutics.